Axsome Therapeutics

AXSMNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$10.639 B

$203.10 -1.16%

Close of 22 Sept 2026

Revenue

$638.5M

#1786 by revenue

Earnings

-$183.2M

Loss-making

Shares outstanding

52,380,818

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#31Madrigal PharmaceuticalsMDGL$12.0B
#32Elanco Animal HealthELAN$11.5B
#33Axsome TherapeuticsAXSM$10.6B
#34Dr Reddys LaboratoriesRDY$10.5B
#35Arrowhead PharmaceuticalsARWR$10.2B

What if Axsome Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$577,195.45

Per share 2,842× higher

Bitcoin $1.74T

$33,249.86

Per share 164× higher

Nvidia $5.52T

$105,301.28

Per share 518× higher

Or at a round number

$20.0B $50.0B $100.0B $200.0B

Where these numbers come from

Share counts and financials for Axsome Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.